BRPI0812966A2 - formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida - Google Patents
formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamidaInfo
- Publication number
- BRPI0812966A2 BRPI0812966A2 BRPI0812966A BRPI0812966A BRPI0812966A2 BR PI0812966 A2 BRPI0812966 A2 BR PI0812966A2 BR PI0812966 A BRPI0812966 A BR PI0812966A BR PI0812966 A BRPI0812966 A BR PI0812966A BR PI0812966 A2 BRPI0812966 A2 BR PI0812966A2
- Authority
- BR
- Brazil
- Prior art keywords
- thiophenecarboxamide
- dimethylphenyl
- isoxazolyl
- sulfonyl
- acetyl
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- IAYNHDZSSDUYHY-UHFFFAOYSA-N n-(2-acetyl-4,6-dimethylphenyl)-3-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]thiophene-2-carboxamide Chemical compound CC(=O)C1=CC(C)=CC(C)=C1NC(=O)C1=C(S(=O)(=O)NC2=C(C(C)=NO2)C)C=CS1 IAYNHDZSSDUYHY-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93721507P | 2007-06-25 | 2007-06-25 | |
| PCT/US2008/007836 WO2009002490A2 (en) | 2007-06-25 | 2008-06-24 | Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0812966A2 true BRPI0812966A2 (pt) | 2017-05-16 |
Family
ID=39720482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0812966A BRPI0812966A2 (pt) | 2007-06-25 | 2008-06-24 | formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080317858A1 (pt) |
| EP (1) | EP2170278A2 (pt) |
| JP (1) | JP2010531357A (pt) |
| KR (1) | KR20100032863A (pt) |
| CN (1) | CN102137655A (pt) |
| AU (1) | AU2008269149A1 (pt) |
| BR (1) | BRPI0812966A2 (pt) |
| CA (1) | CA2689048A1 (pt) |
| IL (1) | IL202513A0 (pt) |
| MX (1) | MX2009013022A (pt) |
| RU (1) | RU2009146836A (pt) |
| WO (1) | WO2009002490A2 (pt) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241417B (it) * | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
| BR0016821A (pt) * | 1999-12-31 | 2002-12-10 | Texas Biotechnology Corp | Sulfonamidas e derivados da mesma que modulam a atividade de endotelina |
| US20020077328A1 (en) * | 2000-07-13 | 2002-06-20 | Fred Hassan | Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain |
| US20030198666A1 (en) * | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
| AU2007282034A1 (en) * | 2006-08-04 | 2008-02-14 | Encysive Pharmaceuticals, Inc. | Polymorphs of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide |
| US20080145433A1 (en) * | 2006-11-09 | 2008-06-19 | Gilead Colorado, Inc. | Darusentan oral dosage form |
-
2008
- 2008-06-24 AU AU2008269149A patent/AU2008269149A1/en not_active Abandoned
- 2008-06-24 KR KR1020097027009A patent/KR20100032863A/ko not_active Ceased
- 2008-06-24 RU RU2009146836/15A patent/RU2009146836A/ru not_active Application Discontinuation
- 2008-06-24 BR BRPI0812966A patent/BRPI0812966A2/pt not_active IP Right Cessation
- 2008-06-24 JP JP2010514778A patent/JP2010531357A/ja not_active Withdrawn
- 2008-06-24 MX MX2009013022A patent/MX2009013022A/es not_active Application Discontinuation
- 2008-06-24 WO PCT/US2008/007836 patent/WO2009002490A2/en not_active Ceased
- 2008-06-24 EP EP08779737A patent/EP2170278A2/en not_active Withdrawn
- 2008-06-24 US US12/145,452 patent/US20080317858A1/en not_active Abandoned
- 2008-06-24 CN CN2008800220860A patent/CN102137655A/zh active Pending
- 2008-06-24 CA CA002689048A patent/CA2689048A1/en not_active Abandoned
-
2009
- 2009-12-03 IL IL202513A patent/IL202513A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100032863A (ko) | 2010-03-26 |
| CN102137655A (zh) | 2011-07-27 |
| US20080317858A1 (en) | 2008-12-25 |
| WO2009002490A3 (en) | 2010-04-08 |
| RU2009146836A (ru) | 2011-07-27 |
| JP2010531357A (ja) | 2010-09-24 |
| EP2170278A2 (en) | 2010-04-07 |
| CA2689048A1 (en) | 2008-12-31 |
| IL202513A0 (en) | 2010-06-30 |
| AU2008269149A1 (en) | 2008-12-31 |
| WO2009002490A2 (en) | 2008-12-31 |
| MX2009013022A (es) | 2010-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200802008A1 (ru) | Фармацевтические композиции | |
| ATE527244T1 (de) | N-(1,1,1,3,3,3-hexafluor-2-hydroxypropan-2- yl)benzyl-n'-arylcarbonylpiperazinderivate als lxr modulatoren | |
| NO20075628L (no) | Farmasøytiske formuleringer | |
| BRPI0511900A (pt) | composições farmacêuticas | |
| SI1998783T1 (sl) | Oftalmični sestavki, ki obsegajo providon-jod | |
| ITBO20050123A1 (it) | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina | |
| BRPI0714539A2 (pt) | "formas farmacêuticas" | |
| DK1811959T4 (da) | Oftalmiske sammensætninger | |
| DK1753434T3 (da) | Forbedret ophthalmisk bimatoprost-oplösning | |
| DK1863474T3 (da) | Hidtil ukendte thiophenderivater som sphingosin-1-phosphat-1-receptoragonister | |
| DK1931702T3 (da) | Silkeproteiner | |
| DE602006011637D1 (de) | N-(hetero)aryl-indolderivate als pestizide | |
| BRPI0719275A2 (pt) | Composições de carbamatos de fenil-alquil-amino | |
| EP1796719A4 (en) | REFRIGERANT TEMPERATURE STABLE FLUID COMPOSITION COMPOSITIONS | |
| EP1858914A4 (en) | NETWORKS OF PEPTIDES | |
| BRPI0715174A2 (pt) | Polimorfos de n-(2-acetil-4,6-dimetilfenil)-2-{[(3,4-dimetil-5-isoxazolil) -amino]sulfonil}-2-tiofenocarboxamida | |
| BRPI0913709A2 (pt) | "formulação farmacêutica" | |
| BRPI0812966A2 (pt) | formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida | |
| DK1784174T3 (da) | Famaceutisk sammensætning omfattende gabapentin | |
| DK1976863T3 (da) | Cykliske antimikrobielle peptider | |
| NO20055220D0 (no) | Avskjaetingslodd for vegmast | |
| PL2069323T3 (pl) | Sposób otrzymywania N-(2-acetylo-4,6-dimetylofenylo)-3-{[(3,4-dimetylo-5-izoksazolilo)amino]sulfonylo}-2-tiofenokarboksyamidu | |
| ITMI20051658A1 (it) | Composizioni cosmetiche | |
| DK2069323T3 (da) | Fremgangsmåder til fremstillingen af N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4-dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophencarboxamid | |
| ATE387189T1 (de) | Sprühgetrocknete pharmazeutische zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |